This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message: Sepsis or genomics or altitude: JKB_daily1
Sent on Thursday, 2012 September 20
Search:
(sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))Click
here to view complete results in PubMed (Results may change over time.)
To unsubscribe from these e-mail updates click
here.
1. | Nat Med. 2012 Jul 6;18(7):1041-51. doi: 10.1038/nm.2829.Bianchi DW.SourceThe Mother Infant Research Institute at Tufts Medical Center and the Division of Genetics, Department of Pediatrics, Floating Hospital for Children, Boston, Massachusetts, USA. dbianchi@tuftsmedicalcenter.org AbstractThus far, the focus of personalized medicine has been the prevention and treatment of conditions that affect adults. Although advances in genetic technology have been applied more frequently to prenatal diagnosis than to fetal treatment, genetic and genomic information is beginning to influence pregnancy management. Recent developments in sequencing the fetal genome combined with progress in understanding fetal physiology using gene expression arrays indicate that we could have the technical capabilities to apply an individualized medicine approach to the fetus. Here I review recent advances in prenatal genetic diagnostics, the challenges associated with these new technologies and how the information derived from them can be used to advance fetal care. Historically, the goal of prenatal diagnosis has been to provide an informed choice to prospective parents. We are now at a point where that goal can and should be expanded to incorporate genetic, genomic and transcriptomic data to develop new approaches to fetal treatment. |
| PMID: 22772565 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
4. | Nat Med. 2012 Jul 6;18(7):1000. doi: 10.1038/nm0712-1000.Dolgin E. |
| PMID: 22772542 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
5. | Nat Med. 2012 Jul 6;18(7):999. doi: 10.1038/nm0712-999.Moyer MW. |
| PMID: 22772541 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
6. | Nat Med. 2012 Jul 6;18(7):998-9. doi: 10.1038/nm0712-998b.Khamsi R. |
| PMID: 22772540 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
7. | Nat Med. 2012 Jul 6;18(7):998. doi: 10.1038/nm0712-998a.Raven K. |
| PMID: 22772539 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
8. | Nat Med. 2012 Jul 6;18(7):997. doi: 10.1038/nm0712-997.[No authors listed] |
| PMID: 22772538 [PubMed - indexed for MEDLINE] |
| Related citations |
|
|
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home